Luye Pharma Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,058.00
910.00
772.00
777.00
-90.00
1,056.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
312.00
-1,542.00
136.00
730.00
-638.00
115.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
2,142.00
153.00
1,737.00
2,482.00
281.00
1,801.00
Cash Flow from Investing Activities
-4,784.00
-572.00
-1,985.00
-949.00
-2,817.00
-60.00
Cash Flow from Financing Activities
2,415.00
2,243.00
448.00
-1,116.00
781.00
509.00
Net Cash Inflow / Outflow
-259.00
1,873.00
85.00
225.00
-1,817.00
2,376.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-32.00
49.00
-114.00
-190.00
-63.00
126.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Luye Pharma Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
1058.71822167372
563.696000000185
495.00
87.82%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
312.000021393006
-250.153000000082
562.00
224.72%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
2142.48459511845
636.095000000208
1,506.00
236.82%
Cash Flow from Investing Activities
-4784.53319050893
29.7630000000098
-4,813.00
-16175.44%
Cash Flow from Financing Activities
2415.20209549924
-293.686000000096
2,708.00
922.38%
Net Cash Inflow / Outflow
-259.127338021836
386.674000000127
-645.00
-167.01%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-32.2808381305976
14.5020000000048
-46.00
-322.60%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 1,297.78% vs -91.18% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
2,142.48
153.28
1,297.78%






